NetworkNewsBreaks – Champignon Brands Inc. (CSE:
Post# of 25
(Total Views: 220)
Posted On: 11/25/2020 4:42:53 PM
NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president of investor and public communications. The company also plans to announce additional board members coming from key business and science segments. Current board members who are remaining include Dr. Roger McIntyre, chair and CEO; Bill Wilkerson, vice chair; Matt Fish, president and secretary; and Jerry Habuda. Concurrent with these announcements, the company noted that Gareth Birdsall, previous director, had resigned earlier this week. These changes are all part of the company’s added emphasis on transparency and full and accurate public reporting along with a commitment to meet the accelerating, pandemic-drive demand for Champignon’s clinical services.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president of investor and public communications. The company also plans to announce additional board members coming from key business and science segments. Current board members who are remaining include Dr. Roger McIntyre, chair and CEO; Bill Wilkerson, vice chair; Matt Fish, president and secretary; and Jerry Habuda. Concurrent with these announcements, the company noted that Gareth Birdsall, previous director, had resigned earlier this week. These changes are all part of the company’s added emphasis on transparency and full and accurate public reporting along with a commitment to meet the accelerating, pandemic-drive demand for Champignon’s clinical services.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)